A diagnostic test kit for screening and detection of BCR-ABL1 fusion transcripts. This kit is designed for initial identification of BCR-ABL1 in suspected chronic myeloid leukemia cases.
Manufactured by
TRUPCR Europe Ltd
Manchester, United Kingdom
TRUPCR Europe Ltd appears to be a technology company with an online presence at trupcr.com. Based on their website, they maintain digital operations that require secure connections and cookie-enabled browsing for optimal functionality. The company serves users through their web platform, prioritizing site security and proper browser configuration for seamless access.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
3B BlackBio Dx - TRUPCR Europe - CORIS BioConcept
India · 8 relevant products
Zeesan Biotech Co., Ltd
China · 1 relevant product
Suzhou Rainsure Scientific Co., Ltd.
China · 1 relevant product
48 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →15 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 18 relevant matches
3B BlackBio Dx - TRUPCR Europe - CORIS BioConcept · India
Real-time PCR kit for quantitative detection and monitoring of BCR-ABL1 fusion transcript in chronic myeloid leukemia. Enables precise measurement of disease burden and treatment response assessment.
HLB PANAGENE Co., Ltd. · South Korea
A molecular diagnostic test for BCR-ABL fusion gene detection in chronic myeloid leukemia and acute lymphoblastic leukemia.
3B BlackBio Dx - TRUPCR Europe - CORIS BioConcept · India
Real-time PCR assay for quantifying PML-RARA fusion transcript in acute promyelocytic leukemia. Enables monitoring of minimal residual disease during ATRA and arsenic trioxide therapy.
15 more relevant matches available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products